Stay updated with breaking news from லீ ஆண்டு எவன்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Columbia Care Announces Launch of West Virginia Market Operations apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Columbia Care Brings Scale to New York Cannabis Program Through Acquisition of One of the Largest Operating Greenhouse Sites on East Coast streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Article content NEW YORK Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the first quarter ended March 31, 2021 before US financial markets open on Monday, May 17, 2021. Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. ET to discuss financial and operating results for the first quarter of 2021. Conference Call and Webcast Details We apologize, but this video has failed to load. Try refreshing your browser, or Columbia Care to Report First Quarter 2021 Results on Monday, May 17, 2021 Back to video ....
Posted on 871 Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced today the launch of its proprietary solid-fill cannabis powder capsule for medicinal use throughout the United Kingdom. This is the first solid-fill capsule of its kind available in the UK and the first dose-metered medicinal cannabis product to be manufactured in the UK. The capsules are part of Columbia Care’s trademarked Ceed medicinal product range. The patent-pending, proprietary capsules were first developed and successfully commercialized in the United States by Columbia Care. They incorporate a portfolio of primary and secondary cannabinoids and are available in a number of formulations with various THC and CBD doses. These dosing options enable prescribing physicians to offer proven, cannabis-based medical solutions with a degree of precision previously unavailabl ....